12 April 2025

Rector of the Baku branch of Sechenov University, surgical oncologist of the head and neck tumor department of the National Oncology Center, Professor Aziz Aliyev delivered a report at the international symposium

The 10th International Symposium on Radiopharmaceutical Treatment, dedicated to radionuclide therapy and nuclear medicine (ISRT 2025), was held in Baku. The symposium was organized by the National Oncology Center of Azerbaijan in collaboration with the Society for Radiation Medicine and the World Association for Radiopharmaceutical and Molecular Therapy (WARMTH).

On the first day of the symposium, international guests visited the Center for Nuclear Medicine and Radionuclide Therapy at the National Oncology Center and learned about its working conditions and processes.

Academician Jamil Aliyev, Director General of the National Oncology Center, met with symposium participants and provided them with extensive information about the Center's development, its operating principles, and the achievements it has achieved in recent years.

Speaking at the opening of the international symposium, Aziz Aliyev, Rector of the Baku Branch of the I.M. Sechenov First Moscow State Medical University and a surgical oncologist in the Head and Neck Tumor Department of the National Oncology Center, MD, Professor, provided information on the state support provided to oncology services in our country. The professor explained that Academician Jamil Aliyev is the founder of a comprehensive oncology service in Azerbaijan and the founder of a magnificent Center that combines cutting-edge technologies and highly qualified specialists, where patients receive comprehensive examination and treatment in a single location.

The ISRT 2025 Symposium brought together influential experts from the United States, Germany, Belgium, Finland, Austria, Italy, Australia, Egypt, Turkey, and other countries to discuss the latest developments in radionuclide therapy. The main goal of the event is to strengthen global scientific collaboration, promote innovative treatment methods, and exchange experience in the clinical use of radiopharmaceuticals.

The first day of the symposium featured leaders from several international organizations, including Kathy Cutler, President of the Society of Nuclear Medicine (SNMMI), Diana Paez, Representative of the International Atomic Energy Agency (IAEA), and Professor Kalevi Kyremo, President of WARMTH. They presented their scientific views on trends, opportunities, and prospects for global collaboration in the field of radionuclide therapy.

IllustrationIllustration
IllustrationIllustration
IllustrationIllustration